Target Name: PSMC1
NCBI ID: G5700
Review Report on PSMC1 Target / Biomarker Content of Review Report on PSMC1 Target / Biomarker
PSMC1
Other Name(s): 26S protease regulatory subunit 4 | NEDGTH | PSMC1 variant 1 | Proteasome 26S subunit, ATPase 1, transcript variant 1 | proteasome 26S ATPase subunit 1 | P26s4 | RPT2 | S4 | 26S proteasome regulatory subunit 4 (isoform a) | p56 | PRS4_HUMAN | Proteasome 26S subunit, ATPase, 1 | 26S proteasome AAA-ATPase subunit RPT2 | proteasome (prosome, macropain) 26S subunit, ATPase, 1 | P26S4 | Proteasome 26S ATPase subunit 1 | 26S proteasome regulatory subunit 4 | Proteasome 26S subunit ATPase 1 | proteasome 26S subunit, ATPase 1

PSMC1: A Potential Drug Target and Biomarker for 26S Protease Regulatory Subunit 4

Protease regulatory subunit 4 (26S rRNA) is a key protein that plays a crucial role in regulating the maturation and degradation of pre-mRNA in eukaryotic cells. The levels of 26S rRNA in a cell are regulated by various factors, including translation efficiency, processing, and degradation.PSMC1, a non-coding RNA molecule known as a microRNA (miRNA), is known to interact with 26S rRNA and regulate its stability and translation efficiency.PSMC1 has also been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. Therefore, it is of great interest as a potential drug target and biomarker.

PSMC1 as a drug target

The potential drug target for PSMC1 is based on its ability to regulate the levels of 26S rRNA in cells. By interacting with 26S rRNA, PSMC1 can either enhance or inhibit its stability and translation efficiency. This interaction between PSMC1 and 26S rRNA makes it a potential drug target for the treatment of various diseases associated with the regulation of 26S rRNA levels, such as cancer, neurodegenerative diseases, and chronic inflammatory diseases.

PSMC1 as a biomarker

PSMC1 has also been shown to serve as a potential biomarker for various diseases. Its interaction with 26S rRNA allows it to be used as a diagnostic tool for diseases associated with the regulation of 26S rRNA levels, such as cancer, neurodegenerative diseases, and chronic inflammatory diseases. The levels of PSMC1 in these diseases are often reduced, and PSMC1 has been shown to play a role in the regulation of cellular processes that are affected by these conditions.

PSMC1 functions as a negative regulator of 26S rRNA

PSMC1 has been shown to function as a negative regulator of 26S rRNA by binding to its active site and inhibiting its translation efficiency. This interaction between PSMC1 and 26S rRNA allows it to regulate the stability and translation efficiency of 26S rRNA.

PSMC1 can also function as a positive regulator of 26S rRNA by binding to its active site and enhancing its stability and translation efficiency. This interaction between PSMC1 and 26S rRNA allows it to regulate the stability and translation efficiency of 26S rRNA in a dose-dependent manner.

PSMC1 is involved in the regulation of cellular processes

PSMC1 is involved in various cellular processes that are important for the regulation of 26S rRNA levels, such as cell growth, apoptosis, and inflammation. Its involvement in these processes is likely due to its ability to regulate the levels of various cellular proteins that are involved in these processes.

PSMC1 can also function as a negative regulator of the translation efficiency of 26S rRNA

PSMC1 has also been shown to function as a negative regulator of the translation efficiency of 26S rRNA. This interaction between PSMC1 and 26S rRNA allows it to regulate the stability and translation efficiency of 26S rRNA in a dose-dependent manner.

Conclusion

PSMC1 is a non-coding RNA molecule that plays a crucial role in regulating the maturation and degradation of pre-mRNA in eukaryotic cells. Its interaction with 26S rRNA allows it to regulate the stability and translation efficiency of 26S rRNA, making it a potential drug target and biomarker for various diseases associated with the regulation of 26S rRNA levels, such as cancer, neurodegenerative diseases, and chronic inflammatory diseases. Further research is needed to fully understand the role of PSMC1 in

Protein Name: Proteasome 26S Subunit, ATPase 1

Functions: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC1 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides

The "PSMC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PSMC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PSMC1P2 | PSMC1P4 | PSMC1P9 | PSMC2 | PSMC3 | PSMC3IP | PSMC4 | PSMC5 | PSMC6 | PSMD1 | PSMD10 | PSMD10P1 | PSMD11 | PSMD12 | PSMD13 | PSMD14 | PSMD2 | PSMD3 | PSMD4 | PSMD4P1 | PSMD5 | PSMD6 | PSMD6-AS2 | PSMD7 | PSMD8 | PSMD9 | PSME1 | PSME2 | PSME2P2 | PSME2P3 | PSME3 | PSME3IP1 | PSME4 | PSMF1 | PSMG1 | PSMG1-PSMG2 heterodimer | PSMG2 | PSMG3 | PSMG3-AS1 | PSMG4 | PSORS1C1 | PSORS1C2 | PSORS1C3 | PSPC1 | PSPH | PSPHP1 | PSPN | PSRC1 | PSTK | PSTPIP1 | PSTPIP2 | PTAFR | PTAR1 | PTBP1 | PTBP2 | PTBP3 | PTCD1 | PTCD2 | PTCD3 | PTCH1 | PTCH2 | PTCHD1 | PTCHD1-AS | PTCHD3 | PTCHD3P1 | PTCHD3P2 | PTCHD4 | PTCRA | PTCSC2 | PTCSC3 | PTDSS1 | PTDSS2 | PTEN | PTENP1 | PTENP1-AS | PTER | PTF1A | PTGDR | PTGDR2 | PTGDS | PTGER1 | PTGER2 | PTGER3 | PTGER4 | PTGER4P2-CDK2AP2P2 | PTGES | PTGES2 | PTGES2-AS1 | PTGES3 | PTGES3L | PTGES3L-AARSD1 | PTGES3P1 | PTGES3P2 | PTGES3P3 | PTGFR | PTGFRN | PTGIR | PTGIS | PTGR1 | PTGR2